Kelly D - Search Results

1

Thompson C, Kneen R, Riordan A, Kelly D, Pollard AJ. Thompson C, et al. Among authors: kelly d. Arch Dis Child. 2012 Feb;97(2):150-61. doi: 10.1136/archdischild-2011-300100. Epub 2011 Jun 28. Arch Dis Child. 2012. PMID: 21715390 Review.

2

Haemophilus influenzae type b conjugate vaccines.

Kelly DF, Moxon ER, Pollard AJ. Kelly DF, et al. Immunology. 2004 Oct;113(2):163-74. doi: 10.1111/j.1365-2567.2004.01971.x. Immunology. 2004. PMID: 15379976 Free PMC article. Review.

3

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine.

Snape MD, Kelly DF, Green B, Moxon ER, Borrow R, Pollard AJ. Snape MD, et al. Among authors: kelly df. Pediatr Infect Dis J. 2005 Feb;24(2):128-31. doi: 10.1097/01.inf.0000151029.58752.27. Pediatr Infect Dis J. 2005. PMID: 15702040

4

Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens.

Kelly DF, Pollard AJ, Moxon ER. Kelly DF, et al. JAMA. 2005 Dec 21;294(23):3019-23. doi: 10.1001/jama.294.23.3019. JAMA. 2005. PMID: 16414950

5

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.

Kelly DF, Snape MD, Clutterbuck EA, Green S, Snowden C, Diggle L, Yu LM, Borkowski A, Moxon ER, Pollard AJ. Kelly DF, et al. Blood. 2006 Oct 15;108(8):2642-7. doi: 10.1182/blood-2006-01-009282. Epub 2006 May 4. Blood. 2006. PMID: 16675705 Free article. Clinical Trial.

6

Effectiveness analyses may underestimate protection of infants after group C meningococcal immunization.

Vu DM, Kelly D, Heath PT, McCarthy ND, Pollard AJ, Granoff DM. Vu DM, et al. Among authors: kelly d. J Infect Dis. 2006 Jul 15;194(2):231-7. doi: 10.1086/505077. Epub 2006 Jun 13. J Infect Dis. 2006. PMID: 16779730

7

Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.

Snape MD, Kelly DF, Salt P, Green S, Snowden C, Diggle L, Borkowski A, Yu LM, Moxon ER, Pollard AJ. Snape MD, et al. Among authors: kelly df. Clin Infect Dis. 2006 Dec 1;43(11):1387-94. doi: 10.1086/508776. Epub 2006 Oct 31. Clin Infect Dis. 2006. PMID: 17083009 Clinical Trial.

8

W135 in Africa: origins, problems and perspectives.

Kelly D, Pollard AJ. Kelly D, et al. Travel Med Infect Dis. 2003 Feb;1(1):19-28. doi: 10.1016/S1477-8939(03)00019-X. Travel Med Infect Dis. 2003. PMID: 17291877

9

Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.

Lee YC, Kelly DF, Yu LM, Slack MP, Booy R, Heath PT, Siegrist CA, Moxon RE, Pollard AJ. Lee YC, et al. Clin Infect Dis. 2008 Jan 15;46(2):186-92. doi: 10.1086/524668. Clin Infect Dis. 2008. PMID: 18171249

10

The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.

Blanchard Rohner G, Snape MD, Kelly DF, John T, Morant A, Yu LM, Borkowski A, Ceddia F, Borrow R, Siegrist CA, Pollard AJ. Blanchard Rohner G, et al. Among authors: kelly df. J Immunol. 2008 Feb 15;180(4):2165-73. doi: 10.4049/jimmunol.180.4.2165. J Immunol. 2008. PMID: 18250423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,240 results

Search Page

Filters